Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1213 ARTÍCULOS , VIENDO DEL 1126 AL 1140

The future of blood-based biomarkers for Alzheimer's disease

Henriksen K, O'Bryant SE, Hampel H, Trojanowski JQ, Montine TJ, Jeromin A, Blennow K, Lönneborg A, Wyss-Coray T, Soares H, Bazenet C, Sjögren M, Hu W, Lovestone S, Karsdal MA, Weiner MW; Blood-Based Biomarker Interest Group.

Alzheimers Dement. 2014 Jan;10(1):115-31. doi: 10.1016/j.jalz.2013.01.013. Epub 2013 Jul 11.

Regional cortical thinning predicts worsening apathy and hallucinations across the Alzheimer disease spectrum

Donovan NJ, Wadsworth LP, Lorius N, Locascio JJ, Rentz DM, Johnson KA, Sperling RA, Marshall GA; Alzheimer Disease Neuroimaging Initiative.

Am J Geriatr Psychiatry. 2014 Nov;22(11):1168-79. doi: 10.1016/j.jagp.2013.03.006. Epub 2013 Jul 24.

Reduced frequency of T lymphocytes expressing CTLA-4 in frontotemporal dementia compared to Alzheimer's disease

Santos RR, Torres KC, Lima GS, Fiamoncini CM, Mapa FC, Pereira PA, Rezende VB, Martins LC, Bicalho MA, Moraes EN, Reis HJ, Teixeira AL, Romano-Silva MA.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:1-5. doi: 10.1016/j.pnpbp.2013.06.019. Epub 2013 Jul 25.

Neuroinflammation in Alzheimer's disease: an understanding of physiology and pathology

Obulesu M, Jhansilakshmi M.

Int J Neurosci. 2014 Apr;124(4):227-35. doi: 10.3109/00207454.2013.831852. Epub 2013 Sep 12.

Simulating effects of biomarker enrichment on Alzheimer's disease prevention trials: conceptual framework and example

Leoutsakos JM, Bartlett AL, Forrester SN, Lyketsos CG.

Alzheimers Dement. 2014 Mar;10(2):152-61. doi: 10.1016/j.jalz.2013.05.1776. Epub 2013 Aug 15.

A comparison of early diagnostic utility of Alzheimer disease biomarkers in brain magnetic resonance and cerebrospinal fluid

Monge Argilés JA, Blanco Cantó MA, Leiva Salinas C, Flors L, Muñoz Ruiz C, Sánchez Payá J, Gasparini Berenguer R, Leiva Santana C.

Neurologia. 2014 Sep;29(7):397-401. doi: 10.1016/j.nrl.2013.06.002. Epub 2013 Aug 20.

Comparing predictors of conversion to Alzheimer's disease using the disease state index

Muñoz-Ruiz MÁ, Hall A, Mattila J, Koikkalainen J, Herukka SK, Vanninen R, Liu Y, Lötjönen J, Soininen H; Alzheimer’s Disease Neuroimaging Initiative.

Neurodegener Dis. 2014;13(2-3):200-2. doi: 10.1159/000354074. Epub 2013 Aug 22.

CD33 in Alzheimer's disease

Jiang T, Yu JT, Hu N, Tan MS, Zhu XC, Tan L.

Mol Neurobiol. 2014 Feb;49(1):529-35. doi: 10.1007/s12035-013-8536-1. Epub 2013 Aug 28.

Biomarkers in pharmacology and drug discovery

Anderson DC, Kodukula K.

Biochem Pharmacol. 2014 Jan 1;87(1):172-88. doi: 10.1016/j.bcp.2013.08.026. Epub 2013 Aug 31.

Progress update: fluid and imaging biomarkers in Alzheimer's disease

Sutphen CL, Fagan AM, Holtzman DM.

Biol Psychiatry. 2014 Apr 1;75(7):520-6. doi: 10.1016/j.biopsych.2013.07.031. Epub 2013 Sep 5.

The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives

Swerdlow RH, Burns JM, Khan SM.

Biochim Biophys Acta. 2014 Aug;1842(8):1219-31. doi: 10.1016/j.bbadis.2013.09.010. Epub 2013 Sep 23.

Biomarker-driven therapeutic management of Alzheimer's disease: establishing the foundations

Cummings J, Zhong K.

Clin Pharmacol Ther. 2014 Jan;95(1):67-77. doi: 10.1038/clpt.2013.205. Epub 2013 Oct 8.

Impact of cerebro-spinal fluid biomarkers of Alzheimer's disease in clinical practice: a multicentric study

Mouton-Liger F, Wallon D, Troussière AC, Yatimi R, Dumurgier J, Magnin E, de la Sayette V, Duron E, Philippi N, Beaufils E, Gabelle A, Croisile B, Robert P, Pasquier F, Hannequin D, Hugon J, Paquet C.

J Neurol. 2014 Jan;261(1):144-51. doi: 10.1007/s00415-013-7160-3. Epub 2013 Oct 27.

Cerebrospinal fluid τ protein in differential diagnosis of Alzheimer's disease and vascular dementia in Chinese population: a meta-analysis

Liu B, Tang Y, Shen Y, Cen L, Han M.

Am J Alzheimers Dis Other Demen. 2014 Mar;29(2):116-22. doi: 10.1177/1533317513507374. Epub 2013 Oct 27.

Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020

Hampel H, Lista S, Teipel SJ, Garaci F, Nisticò R, Blennow K, Zetterberg H, Bertram L, Duyckaerts C, Bakardjian H, Drzezga A, Colliot O, Epelbaum S, Broich K, Lehéricy S, Brice A, Khachaturian ZS, Aisen PS, Dubois B.

Biochem Pharmacol. 2014 Apr 15;88(4):426-49. doi: 10.1016/j.bcp.2013.11.009. Epub 2013 Nov 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias